Global Asthma Therapeutics Market to Grow 4.31% by 2020 - Huge Market Potential for mAbs - Research and Markets

News provided by

Research and Markets

15 Aug, 2016, 02:10 ET

DUBLIN, August 15, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Asthma Therapeutics Market 2016-2020" report to their offering.

The report forecasts the global asthma therapeutics market to grow at a CAGR of 4.31% during the period 2016-2020.

One of the key trends for market growth will be innovative technologies for drug delivery. The industry's shift toward electronic systems technology like smart technology and EHR brings the level of perspective and accessibility across healthcare specialties. This reduces cost when administering expensive medications. Other recent advances include integration of add-on devices such as spacers, breath-actuated devices, and valved holding chambers in inhalers. They help in reducing oropharyngeal deposition of inhaled corticosteroids and minimizes side effects.

According to the report, one of the key drivers for market growth will be huge market potential for mAbs. mAbs will have a high uptake for the treatment of asthma, owing to the development of target specific drugs. mAbs blocking IgE are specifically approved for the treatment of allergic asthma. Asthmatic patients with phenotypes of severe refractory asthma will benefit from these mAbs. mAbs against immunoglobulin or specific cytokines, which are known to be important in the initiation or persistence of asthmatic inflammation are being developed. Xolair was the first mAb approved for the treatment of allergic asthma.

Further, the report states that once of the challenges for the market will be increased preference for CAM.

Key vendors:

  • AstraZeneca
  • Boehringer Ingelheim
  • F. Hoffmann-La Roche
  • GSK
  • Merck

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Pipeline portfolio

PART 06: Market landscape

PART 07: Key buying criteria for asthma drugs

PART 08: Market segmentation by type of treatment

PART 09: Market segmentation by drug class

PART 10: Segmentation by route of administration

PART 11: Drug delivery devices market for asthma drugs

PART 12: Geographical segmentation

PART 13: Market drivers

PART 14: Impact of drivers

PART 15: Market challenges

PART 16: Impact of drivers and challenges

PART 17: Market trends

PART 18: Vendor landscape

PART 19: Key vendor analysis

PART 20: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/s7df5f/global_asthma

Related Topics: Asthma Drugs

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com

Also from this source

Global and China Automotive Gateway Industry Report 2023: Integrated Gateways have Become an Important Trend in Zonal Architecture

MEMS Technology Revolutionizes Healthcare: Advancements in Sensor Types and Applications

Explore

More news releases in similar topics

PRN Top Stories Newsletters

Sign up to get PRN’s top stories and curated news delivered to your inbox weekly!

Thank you for subscribing!

By signing up you agree to receive content from us.
Our newsletters contain tracking pixels to help us deliver unique content based on each subscriber's engagement and interests. For more information on how we will use your data to ensure we send you relevant content please visit our PRN Consumer Newsletter Privacy Notice. You can withdraw your consent at any time in the footer of every email you'll receive. Mit Ihrer Anmeldung erklären Sie sich damit einverstanden, Inhalte von uns zu erhalten.
Unsere Newsletter enthalten Zählpixel, die die Lieferung einzigartiger Inhalte in Bezug auf das Abonnement und die Interessen der einzelnen Abonnenten ermöglichen. Weitere Informationen über die Verwendung Ihrer Daten im Hinblick auf die Zusendung von relevanten Inhalten, finden Sie in unserer PRN Consumer Newsletter Privacy Notice. Ihre Zustimmung können Sie jederzeit in der Fußzeile jeder erhaltenen E-Mail widerrufen. En vous inscrivant à la newsletter, vous consentez à la réception de contenus de notre part.
Notre newsletter contient des pixels espions nous permettant la fourniture à chaque abonné, d’un contenu unique en lien avec ses souscriptions et intérêts. Pour de plus amples informations sur l’utilisation faite de vos données en vue de l’envoi des contenus concernés, nous vous invitons à consulter la politique de confidentialité disponible à partir du lien suivant PRN Consumer Newsletter Privacy Notice. Vous pouvez à tout moment revenir sur votre consentement par le biais des informations situées au bas de chaque e-mail reçu. Регистрирайки се, Вие се съгласявате да получавате информационно съдържание от нас. Нашите бюлетини съдържат проследяващи пиксели, които ни помагат да предоставяме уникално съдържание въз основа на ангажираността и интересите на всеки абонат. За повече информация относно начина, по който ще използваме Вашите данни, за да гарантираме, че Ви изпращаме подходящо съдържание, моля, направете справка с нашето Уведомление за поверителност на потребителския бюлетин на PRN. Можете да оттеглите съгласието си по всяко време в долния колонтитул на всеки от имейлите, които ще получите.